1 study found for:    3361530 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma
Condition: Scleroderma
Interventions: Drug: Imatinib mesylate;   Other: Placebo

Indicates status has not been verified in more than two years